FENNEC PHARMACEUTICALS INC. — Director's Dealing 2018

Mar 29, 2018

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: FENNEC PHARMACEUTICALS INC. (FENC)
CIK: 0001211583
Period of Report: 2016-01-01

Reporting Person: MANCHESTER MANAGEMENT PR, LLC (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2017357	Indirect

Footnotes

F1: Manchester Management PR, LLC, a Puerto Rico limited liability company, provides investment management services to private individuals and institutions. The reported securities are indirectly beneficially owned by Manchester Management PR, LLC as a result of it having investment discretion over certain advisory accounts it manages. The reported securities and warrants may also be deemed to be indirectly beneficially owned by James E. Besser, as the Managing Member of Manchester Management PR, LLC. Each of the Reporting Persons disclaim beneficial ownership of the reported securities and warrants except to the extent of their pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Persons are the beneficial owners of the securities and warrants for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.